Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry | Zendy

Fabrizio D’Ascenzo | Zendy; Dario Celentani | Zendy; Alessandro Brustio | Zendy; Alberto Grosso | Zendy; Sergio RaposeirasRoubín | Zendy; Emad AbuAssi | Zendy; José P.S. Henriques | Zendy; Jorge Saucedo | Zendy; José Ramón González–Juanatey | Zendy; Stephen B. Wilton | Zendy; Wouter J. Kikkert | Zendy; Iván J. NúñezGil | Zendy; Albert ArizaSolé | Zendy; Xiantao Song | Zendy; Dimitrios Alexopoulos | Zendy; Christoph Liebetrau | Zendy; Tetsuma Kawaji | Zendy; Ze Huczek | Zendy; Shaoping Nie | Zendy; Toshiharu Fujii | Zendy; Luis Correia | Zendy; Masaaki Kawashiri | Zendy; José Marı́a Garcı́a-Acuña | Zendy; Danielle A. Southern | Zendy; Emilio Alfonso | Zendy; Belén Terol | Zendy; Alberto Garay | Zendy; Dongfeng Zhang | Zendy; Yalei Chen | Zendy; Ioanna Xanthopoulou | Zendy; Neriman Osman | Zendy; Helge Möllmann | Zendy; Hiroki Shiomi | Zendy; Michał Kowara | Zendy; Krzysztof J. Filipiak‬ | Zendy; Xiao Wang | Zendy; Yan Yan | Zendy; Jingyao Fan | Zendy; Yuji Ikari | Zendy; Takuya Nakahayshi | Zendy; Kenji Sakata | Zendy; Masakazu Yamagishi | Zendy; Oliver Kalpak | Zendy; Saško Kedev | Zendy; Claudio Moretti | Zendy; Maurizio D’Amico | Zendy; Fiorenzo Gaita | Zendy

Open Access

Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry

Author(s) -

Fabrizio D’Ascenzo,

Dario Celentani,

Alessandro Brustio,

Alberto Grosso,

Sergio RaposeirasRoubín,

Emad AbuAssi,

José P.S. Henriques,

Jorge Saucedo,

José Ramón González–Juanatey,

Stephen B. Wilton,

Wouter J. Kikkert,

Iván J. NúñezGil,

Albert ArizaSolé,

Xiantao Song,

Dimitrios Alexopoulos,

Christoph Liebetrau,

Tetsuma Kawaji,

Ze Huczek,

Shaoping Nie,

Toshiharu Fujii,

Luis Correia,

Masaaki Kawashiri,

José Marı́a Garcı́a-Acuña,

Danielle A. Southern,

Emilio Alfonso,

Belén Terol,

Alberto Garay,

Dongfeng Zhang,

Yalei Chen,

Ioanna Xanthopoulou,

Neriman Osman,

Helge Möllmann,

Hiroki Shiomi,

Michał Kowara,

Krzysztof J. Filipiak‬,

Xiao Wang,

Yan Yan,

Jingyao Fan,

Yuji Ikari,

Takuya Nakahayshi,

Kenji Sakata,

Masakazu Yamagishi,

Oliver Kalpak,

Saško Kedev,

Claudio Moretti,

Maurizio D’Amico,

Fiorenzo Gaita

Publication year - 2018

Publication title -

american journal of cardiovascular drugs

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.063

H-Index - 50

eISSN - 1179-187X

pISSN - 1175-3277

DOI - 10.1007/s40256-018-0273-4

Subject(s) - medicine , myocardial infarction , conventional pci , percutaneous coronary intervention , clinical endpoint , propensity score matching , cardiology , ejection fraction , unstable angina , revascularization , heart failure , acute coronary syndrome , randomized controlled trial

The aim was to evaluate prognostic value of beta-blocker (BB) administration in acute coronary syndromes (ACS) patients in the percutaneous coronary intervention (PCI) era.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research